TSO3 IncTSX: TOS

TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer

· Issued by TSO3 Inc via CNW

Company Contact: TSO, Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com; Investor Relations: Liolios Group, Inc., Chris Tyson, Tel: 949 574-3860, TOS@liolios.com; Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, bmire@renmakfinancial.comCopyright CNW Group 2015

View original source (CNW)TSO3 Inc on 6ix

Earlier from TSO3

Later from TSO3

All TSO3 news releases